Company: HCTI
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112544
Chunk: 46

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 46
---
ly issued, fully paid,
and non-assessable and will not have, or be subject to, any preemptive or similar rights.

<div align='center'>15</div>

Section 242 of DGCL provides that the holders
of each class or series of stock will have the right to vote separately as a class on certain amendments to our certificate of incorporation,
as amended, that would affect the class or series of preferred stock, as applicable. This right is in addition to any voting rights that
may be provided for in the applicable certificate of designation.

Series A Super Voting Preferred Stock

The following is a summary of the terms of our
Series A Super Voting Preferred Stock

Voting Rights. Each share of our
Super Voting Preferred Stock entitles its holder to 1,000 votes per share and votes with our common stock as a single class on all matters
to be voted or consented upon by the stockholders.

Dividend Rights. The holders of
our Super Voting Preferred Stock are not entitled to any dividend rights.

Liquidation Rights. The holders
of our Super Voting Preferred Stock are not entitled to any liquidation preference.

Other Matters. The holders of our
Super Voting Preferred Stock have no subscription, redemption or conversion privileges and are not subject to redemption. Our Super Voting
Preferred Stock does not entitle its holders to pre-emptive rights. All of the outstanding shares of our Super Voting Preferred Stock
are fully paid and non-assessable.

Our Board also has the authority to issue up to
9,980,000 additional shares of preferred stock in one or more classes or series and to fix the designations, powers, preferences, and
rights, and the qualifications, limitations, or restrictions thereof including dividend rights, dividend rates, conversion rights, voting
rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any class or series, without
further vote or action by the stockholders.

While we do not currently have any plans for the
issuance of any additional preferred stock, the issuance of additional preferred stock could adversely affect the rights of the holders
of common stock and, therefore, reduce the value of the common stock. It is not possible to state the actual effect of the issuance of
any shares of preferred stock on the rights of holders of the common stock until the Board determines the specific rights of the holders
of the preferred stock; however, these effects may include:

| ● | Restricting                    
 dividends on the common stock